The designed proteins block hemoglobin from binding ChuA, an outer membrane bacterial protein, helping to inhibit E. coli's growth.

Merck & Co. has agreed to acquire Verona Pharma for $10 billion, the companies said, in a deal designed to expand the pharma ...

GREmLN leverages a graph-based architecture to represent gene-gene interactions to predict cell behavior for therapeutic ...

Pharmaceutical manufacturers are under immense pressure to streamline their processes, reduce waste, and improve output.

CZI and the IGI announce the funding of the Center for Pediatric CRISPR Cures to use CRISPR-based editing technology to advance cures.

Revolution Medicines' proprietary data will train a bespoke version of NeuralPLexer, an AI model for protein-ligand ...

Methylation changes in microbiome-derived cfRNA enable more accurate CRC diagnosis than traditional DNA or abundance-based ...

Mouse livers were engineered via a one-time genome editing to secrete a GLP-1, cutting weight gain and improving glucose ...

Researchers predict that industry adoption of continuous manufacturing will accelerate in response to competitive pressure.

Results reveal that weight loss has significant effects on cellular processes that are known to affect metabolic health and ...

The potential of gene therapies will only be realized if the manufacturing challenges can be resolved, and that’s a tricky ...

The best way to ensure consistency as bioassays are transferred among labs and scaled up is to plan early on for those ...